Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Japanese Encephalitis”

85 trials

Showing 20 of 85 results

Post-approval studies (Phase 4)Active Not RecruitingNCT06825312
What this trial is testing

Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis

Who this might be right for
Japanese Encephalitis Vaccine
Liaoning Chengda Biotechnology CO., LTD 600
Testing effectiveness (Phase 2)Study completedNCT00441259
What this trial is testing

Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age

Who this might be right for
Japanese Encephalitis
Sanofi 96
Not applicableNot Yet RecruitingNCT06674837
What this trial is testing

Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis Virus

Who this might be right for
Japanese Encephalitis
ANRS, Emerging Infectious Diseases 4,000
Large-scale testing (Phase 3)Study completedNCT02545517
What this trial is testing

Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.

Who this might be right for
Virus DiseasesRabies
GlaxoSmithKline 459
Post-approval studies (Phase 4)Study completedNCT00463476
What this trial is testing

Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine

Who this might be right for
Japanese Encephalitis
PATH 305
Testing effectiveness (Phase 2)Study completedNCT00981175
What this trial is testing

ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults

Who this might be right for
EncephalitisJapanese Encephalitis
Sanofi 202
Testing effectiveness (Phase 2)Study completedNCT00982137
What this trial is testing

Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)

Who this might be right for
Japanese EncephalitisYellow Fever
Sanofi 108
Post-approval studies (Phase 4)UnknownNCT01954810
What this trial is testing

Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children

Who this might be right for
Japanese Encephalitis
Khon Kaen University 88
Not applicableUnknownNCT01163123
What this trial is testing

Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, Taiwan

Who this might be right for
Japanese Encephalitis
Mennonite Christian Hospital 312
Not applicableStudy completedNCT00596102
What this trial is testing

Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 3,258
Large-scale testing (Phase 3)Study completedNCT03282370
What this trial is testing

Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam

Who this might be right for
Japanese Encephalitis
National Institute of Hygiene and Epidemiology, Vietnam 655
Testing effectiveness (Phase 2)Study completedNCT01943305
What this trial is testing

The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans

Who this might be right for
Yellow FeverEncephalitis, Japanese
Singapore General Hospital 84
Large-scale testing (Phase 3)UnknownNCT04223037
What this trial is testing

Purified Inactivated Japanese Encephalitis Vaccine

Who this might be right for
Japanese Encephalitis Virus Disease
Chinese Academy of Medical Sciences 1,050
Large-scale testing (Phase 3)Study completedNCT01246479
What this trial is testing

Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 23
Large-scale testing (Phase 3)Study completedNCT00595309
What this trial is testing

Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 198
Post-approval studies (Phase 4)Study completedNCT00463684
What this trial is testing

Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age

Who this might be right for
Japanese Encephalitis
PATH 278
Large-scale testing (Phase 3)Study completedNCT00249769
What this trial is testing

Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine

Who this might be right for
Encephalitis, Japanese B
PATH 600
Post-approval studies (Phase 4)Study completedNCT01815073
What this trial is testing

Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine

Who this might be right for
Japanese EncephalitisChickenpox
Changchun Keygen Biological Products Co., Ltd. 497
Post-approval studies (Phase 4)Study completedNCT01656200
What this trial is testing

A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2

Who this might be right for
Japanese EncephalitisJapanese Encephalitis Vaccine
Indian Institute of Science 17
Post-approval studies (Phase 4)Study completedNCT02514746
What this trial is testing

Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose

Who this might be right for
Encephalitis, Japanese
PATH 561
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation